To examine the impact of C-reactive protein on the risks of stroke and its subtypes, particularly among Asian populations in which median C-reactive protein levels are typically lower than in Western populations. Methods: A prospective, nested case-control study was conducted to examine the associations between high sensitivity-CRP (hs-CRP) and risks of cardiovascular disease within a cohort of 29,876 men and women aged 40-69 years, with no history of stroke, ischemic heart disease or cancer, who submitted blood samples between 1990 and 1993. Systematic cardiovascular surveillance was performed throughout 2007. One control for each stroke and two controls for each ischemic heart disease were matched for sex, age, date of blood drawing, time since last meal and study location. Results: We documented 1,132 incident strokes (638 ischemic and 494 hemorrhagic strokes) and 209 ischemic heart diseases (168 myocardial infarctions and 41 sudden cardiac deaths), and observed a linear association between hs-CRP levels and risks of ischemic stroke and ischemic heart disease, more specifically myocardial infarction. The multivariable odds ratios associated with 1-SD increment of logarithmically transformed hs-CRP were 1.13 (0.99-1.29), p=0.07 for ischemic stroke, 1.16 (0.96-1.41), p=0.13 for lacunar infarction, 1.41 (0.98-2.01), p=0.06 for embolic infarction, and 1.28 (1.03-1.59), p= 0.03 for myocardial infarction. The predictive value of hs-CRP for ischemic stroke was reduced primarily after adjustment for hypertensive status and body mass index. No association was found between hs-CRP levels and the risk of hemorrhagic or total stroke. Conclusions: High serum hs-CRP levels were associated with the risk of myocardial infarction and more weakly with the risk of ischemic stroke among middle-aged Japanese men and women. 
Introduction
Evidence from several previous prospective studies has demonstrated that elevated C-reactive protein (CRP) is associated with an increased risk for ischemic heart disease 1, 2) , but not hemorrhagic stroke [3] [4] [5] . It remains unclear whether CRP is associated with an increased risk of ischemic stroke, including various subtypes such as lacunar, large-artery occlusive and embolic infarctions.
The association between high-sensitivity CRP (hs-CRP) and ischemic stroke has been reported inconsistently between studies for different age groups. Some studies [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] have demonstrated a positive association between the two while others have reported no scope of the questionnaire included personal and family medical histories, psychosocial factors such as perceived stress, household structure, and occupation, and lifestyle behaviors and factors such as smoking, alcohol, diet, and physical activity.
A total of 34,085 residents (29%) agreed to provide 10 mL samples of venous blood that was drawn into Vacutainer tubes containing heparin. Samples were collected at the time of health examinations conducted by municipal governments during the same year as the baseline survey. Samples were divided into plasma and buffy coat layers, and preserved at −80 ℃ until analysis. Of these blood samples, 55% were fasting samples (taken ≥ 4 hours after the last meal).
Follow-Up Surveillance
Study subjects were followed up until December 31, 2007. Those having died or moved to other municipalities were identified annually through residential registries in their Public Health Center areas. Of the original study sample, 9.9% had moved away and 0.2% was lost to follow-up during the study period.
Confirmation of Ischemic Heart Disease and Stroke Incidence
A total of 64 hospitals were registered within administrative districts of the JPHC cohort. All were major hospitals with the capacity of managing patients with acute ischemic heart disease and stroke. Physicians who were blinded to patient lifestyle data reviewed the medical records at each hospital. Acute ischemic and stroke events were included in the study if they occurred after the date of return of the baseline questionnaire and before January 1, 2008.
Myocardial infarction was confirmed in medical records according to the criteria put forward in the MONICA (Monitoring Trends and Determinants of Cardiovascular Disease) project 21) , which requires chest pain, evidence from electrocardiogram (ECG), cardiac enzymes, and/or autopsy. Cases with definite and probable myocardial infarctions were used for the analyses. In the absence of a diagnosis of myocardial infarction, deaths that occurred within 1 hour from the onset of symptoms were regarded as sudden cardiac deaths.
Strokes were confirmed according to the National Survey of Stroke criteria 22) , which require the presence of focal neurological deficits of sudden or rapid onset lasting at least 24 hours or until death. Strokes were further classified as subarachnoid hemorrhage, intraparenchymal hemorrhage, or as an ischemic stroke subtype (large-artery occlusive stroke, embolic stroke or lacunar stroke). All registered hospiassociation 5, 16) . Since ischemic stroke subtypes (lacunar, large-artery occlusive and embolic infarctions) often exhibit different pathological and etiological characteristics 17, 18) , inconsistencies in previous investigations may have stemmed from the over-representation of certain subtypes within the given cohort.
A cohort study of elderly European men and women demonstrated a weak association between hs-CRP and the risks of both lacunar and large-artery occlusive infarction.3 In this study, however, potential confounding factors were not accounted for, possibly due to the small number of incident cases. Conversely, another 3-year follow-up study showed no association between hs-CRP and the risk of lacunar infarction 19) . The aim of this study was to examine the relationship between hs-CRP levels with the risks of stroke and its subtypes, as well as the risk of ischemic heart disease. In this study, blood samples were collected from a nested-case control cohort of approximately 30,000 subjects, a subset derived from a larger prospective cohort of the Japan Public Health Centerbased Prospective Study (JPHC Study).
Materials and Methods

Study Population
The first and second cohorts of the Japan Public Health Center-based Prospective Study (JPHC Study) were initiated in 11 public health center areas throughout the country 20) in 1990 (Cohort-Ⅰ) and 1993 (Cohort-Ⅱ). Two public health center areas (Tokyo and Osaka) were excluded from the present study because cardiovascular disease incidence data were not available. The study population of the present study was defined as all residents (n = 116,896) aged 40-59 years for Cohort-I and 40-69 years for Cohort-Ⅱ at baseline. Exclusion criteria included nonJapanese nationality (n = 51), late reports of emigration occurring before the start of the follow-up period (n = 166), and incorrect birth date (n = 3). As a result, 116,676 residents remained eligible for the study.
A self-administered baseline questionnaire on lifestyle factors was presented to residents in 1993 and 1994. The overall response rate was 82% (n = 95,374) and these residents were included in the study cohort. The present study was approved by the institutional review board of the National Cancer Center, Tokyo, Japan and Osaka University.
Baseline Questionnaire Survey and Blood Collection
A self-administered baseline questionnaire on lifestyle was presented to participants in 1990 for Cohort Ⅰ and in 1993 and 1994 for Cohort Ⅱ. The Wilcoxon rank-sum test was used to compare the median values of baseline hs-CRP levels between case and control subjects. The χ 2 test was used to compare proportions between these two groups.
The conditional odds ratio (OR) and 95% confidence interval (95% CI) of stroke subtypes and ischemic heart disease were estimated according to quartiles of hs-CRP levels using the conditional logistic regression model. Adjustments for potential confounding variables such as systolic blood pressure (mmHg), anti-hypertensive medication use (yes vs. no), sex-specific quartiles of body mass index (BMI) (kg/m 2 ), smoking status (never, ex-, and current smokers), alcohol intake (non-current drinkers, occasional drinkers, current drinkers), serum total cholesterol (mmol/L), lipid-lowering medication use (yes vs. no) and glucose category (normal, borderline or diabetes mellitus) were applied for multivariable analysis.
Borderline diabetes mellitus was defined as a fasting glucose of 6.1-6.9 mmol/L or a non-fasting glucose level of 7.8-11.0 mmol/L. Diabetes mellitus was defined as a fasting glucose level of ＞7.0 mmol/L, a non-fasting glucose level of ＞11.1 mmol/L, or the use of diabetes medication.
We also checked for statistical interactions using cross-product terms of sex with logarithmically transformed hs-CRP. To examine the extent to which established cardiovascular risk factors potentially confounded the effect of hs-CRP on cardiovascular disease, we calculated the magnitude of change in the ORs for 1-SD increment of logarithmically transformed hs-CRP before (crude model) and after (adjusted model) adjustment for each risk factor. The proportion of reduced excess risk explained by each set of risk factors was computed as follows 28) :
To confirm whether the addition of hs-CRP to other risk factors improved the prediction of total stroke, stroke subtypes and ischemic heart disease, we calculated integrated discrimination improvement (IDI) 29) . All analyses were conducted using the SAS statistical package version 9.1 (SAS Institute Inc., Cary, NC). The statistical analyses were two-tailed and p＜ 0.05 was regarded as significant.
Results
Table 1
shows the risk characteristics of stroke, stroke subtypes and ischemic heart disease for the case-control subjects. The average ages at baseline survey during 1990 to 1993 fell between 55 and 58 years tals had the appropriate equipment to carry out computer tomographic (CT) or magnetic resonance imaging (MRI). Definite diagnoses were established based on the examination of CT or MRI images 23) , and definite stroke cases were used for the analyses.
Selection of Cases and Controls
During the study period, 1,132 strokes and 209 ischemic heart disease events were reported among the 29,876 subjects (10,334 men and 19,542 women) who had returned the baseline questionnaire with no prior history of myocardial infarction, angina pectoris, stroke, or cancer, and had provided blood samples.
One control for each stroke case and two controls for each ischemic heart disease case were selected using incidence-density sampling 24) . Controls were matched for sex, age (within 3 years), date of blood drawing (within 6 months), time since last meal (within 5 hr) and study location (Public Health Center area).
Laboratory Assays
Hs-CRP levels were measured using an ultra-sensitive latex-enhanced immunoassay with an automatic analyzer (BN Prospec nephlometer; Dade Behring, Newark, DE) at Kotobikan Medical Laboratory of Tsukuba and Osaka Medical Center for Health Science and Promotion. All laboratory personnel were blinded to the case or control status. The laboratory was included in the quality control study. Each of the five samples were assayed in quadruplicate on 20 different days along with a single daily measurement of an internal quality control sample 25) . The inter-assay and intra-assay coefficients of variation from the quality control samples were 1.3% and 1.4%, respectively. The hs-CRP precision was satisfactory based on the AHA/CDC scientific statement: the coefficients of variations ＜10% in the range of hs-CRP between 0.3 and 10 mg/L 26) . Serum total cholesterol was measured by enzymatic methods in 23 laboratories. According to Osaka Medical Center for Health Science and Promotion, a member of the US Cholesterol Reference Method Laboratory Network 27) , the precision and accuracy for the cholesterol measurement in all laboratories were found satisfactory; mean coefficient of variation was 0.78% for precision, and mean percent bias vs. the target value was ±0.30%.
Statistical Analysis
The t -test was used to compare mean values of baseline cardiovascular risk factors between case and control subjects. Due to skewed hs-CRP levels, The was no association between hs-CRP and the risk of hemorrhagic stroke or sudden cardiac death. We calculated the proportion of hs-CRP-related reduction in excess risk explained by each set of risk factors (Fig. 1) . The large proportions of excess risks from high hs-CRP for total stroke and ischemic heart disease were explained by potential confounding factors, 83% and 58%, respectively. The respective percentages for ischemic stroke and myocardial infarction were 43% and 39%. When we examined each set of risk factors, systolic blood pressure, antihypertensive medication use, and body mass index had the largest contribution to excess risks. For example, the percentage of hs-CRP-related reduction in the excess risk of total stroke was 42% for systolic blood pressure, 33% for antihypertensive medication use, and 33% for body mass index.
The addition of hs-CRP to the other risk factors improved the prediction of ischemic stroke, ischemic heart disease and myocardial infarction to some extent, but did not improve the prediction of total stroke (not shown in Table) . The IDI was 0.39% (p = 0.008) for ischemic stroke, 0.58% (p = 0.04) for ischemic heart disease and 1.29% (p = 0.01) for myocardial infarction, but only 0.017% (p = 0.39) for total stroke.
Discussion
In the present population-based prospective study of Japanese men and women, associations between hs-CRP and risks of ischemic stroke, particularly embolic stroke and ischemic heart disease, were observed. The excess risks associated with higher hs-CRP, although remaining statistically significant for myocardial infarction, were attenuated substantially after adjustment for hypertensive status and body mass index.
A weak positive association between hs-CRP and risk of lacunar infarction, although not statistically significant in the multivariable analysis in the present study, was consistent with the findings from previous studies 3, 4) . The lack of an association between hs-CRP and hemorrhagic stroke risk has also been reflected in previous findings [3] [4] [5] . The potential confounding factors accounted for about half of the hs-CRP-related excess risk of ischemic cardiovascular disease. In particular, systolic blood pressure, antihypertensive medication use, and body mass index contributed significantly to this. Previous studies have also shown a similar risk reduction for ischemic stroke among elderly European men 3) , American men and women 10, 11) , elderly Japaneseamong both stroke and ischemic heart disease cases and controls. The proportion of men in each of the events was 52% for total stroke, 57% for ischemic stroke, 44% for hemorrhagic stroke, and 64% for ischemic heart disease. The prevalence of ever smoking, anti-hypertensive medication use, and diabetes was higher in both ischemic stroke and ischemic heart disease cases than in their respective controls. Mean values of systolic and diastolic blood pressures were also higher for all types of stroke (except for subarachnoid hemorrhage) and ischemic heart disease than their controls. Cases of ischemic stroke and ischemic heart disease recorded higher mean values of total cholesterol and body mass index than their controls; however, the prevalence of current drinkers was lower for ischemic heart disease than for controls. Median values of hs-CRP were higher in cases of total stroke, ischemic stroke, lacunar infarction, embolic infarction, ischemic heart disease and myocardial infarction than in controls. During 1990 to 2007, we identified 1,341 incident cardiovascular disease events including 1,132 cases of stroke (583 men and 549 women), and 209 cases of ischemic heart disease (133 men and 76 women). Stroke cases comprised 638 ischemic strokes (307 lacunar, 156 large-artery occlusive and 127 embolic infarctions) and 494 hemorrhagic strokes (344 intraparenchymal hemorrhages and 150 subarachnoid hemorrhages). Ischemic heart disease comprised 168 myocardial infarction and 41 sudden cardiac deaths. Table 2 shows matched and multivariable conditional OR (95% CI) for stroke, its subtypes and ischemic heart disease according to hs-CRP levels. We observed an increased risk of ischemic stroke, more specifically lacunar infarction and embolic infarction, ischemic heart disease and myocardial infarction with higher hs-CRP levels. These associations were attenuated substantially after adjustment for potential confounding variables, but linear associations remained significant for myocardial infarction and were of borderline significance for ischemic stroke. The multivariable conditional odds ratio (95% CI) with 1-SD increment of logarithmically transformed hs-CRP level was 1.13 (95% CI, 0.99-1.29; p = 0.07) for ischemic stroke, 1.16 (95% CI, 0.96-1.39; p = 0.13) for ischemic heart disease, and 1.28 (95% CI, 1.03-1.59; p = 0.03) for myocardial infarction. A positive association of borderline significance was observed for embolic infarction: the multivariable odds ratio was 1.41(95% CI, 0.98-2.01; p = 0.06. The positive associations between hs-CRP and risk of ischemic stroke and ischemic heart disease did not vary by sex. There Further adjusted for body mass index, smoking status, alcohol intake, serum total cholesterol, lipid-lowering medication use, systolic blood pressure, anti-hypertensive medication use and serum glucose category. ‡ 1SD of logarithmically transformed hs-CRP was 1.14. ine the CRP-disease associations. The hs-CRP was measured with a standardized method with satisfactory reliability and precision, which appears to make our findings comparable with those of other studies 43) . Furthermore, the number of incident stroke cases (n = 1,132), confirmed by the imaging studies, was the largest among the previous cohort studies [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . That allowed us to investigate the association between hs-CRP and the risk of total stroke as well as stroke subtypes.
The present study had several potential limitations. Firstly, only 29% of the original study sample provided blood samples at baseline, representing only a small proportion of the general population; however, there was no major difference in baseline characteristics between subjects who provided baseline blood samples and those who did not. Despite this, generalizing the findings of this study to a larger population needs to be performed carefully, particularly in view of previous reports 44) showing the difficulty of extrapolating risk estimates from a sub-cohort to an entire cohort. Another potential limitation involves the use of frozen serum samples to estimate hs-CRP concentrations, which may have affected the accuracy of these readings. Although we did not monitor longterm changes in hs-CRP levels of stored serum samples, previous studies have confirmed that hs-CRP levels are stable in serum samples stored for up to 7 years at −70 ℃ 45) .
In conclusion, the present study provides epidemiological evidence that hs-CRP may predict the incidence of myocardial infarction and, to lesser extent, ischemic stroke among middle-aged Japanese men and women. The predictive values of hs-CRP were reduced primarily after adjustment for hypertensive status and body mass index. American men 12) , and Japanese women 4) after adjustment for potential confounding factors, although the contribution of each individual confounding factor was not reported in these studies.
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